Glen J. Weiss
Clinical Associate Professor
Cancer and Cell Biology Division
Translational Genomics Research Institute
United States of America
Biography
Dr. Glen Weiss is a Translational Physician Scientist (TPS) with a joint appointment at TGen and Cancer Treatment Centers of America. He is board certified in internal medicine and medical oncology. He is currently Co-Head of the Lung Cancer Unit and Clinical Associate Professor at TGen, Director of Clinical Research at Cancer Treatment Centers of America, and holds a Clinical Assistant Professor of Medicine appointment at the University of Arizona College of Medicine-Phoenix.
Research Interest
Internal medicine and medical oncology, genomic and other 'omics characterization of lung cancer, rare cancers, cancer therapeutic agents.
Publications
-
Progression-free Survival Decreases with Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials. J Cancer 3: 7-13, 2012
-
Factors Influencing Time to Determination of the Recommended Phase 2 Dose in Phase 1 Clinical Trials. Am J Clin Oncol, 2012 Feb 6.
-
Progression-free Survival Decreases with Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials. J Cancer 3: 7-13, 2012.
-
Phase 1 Dose-escalation Study to Examine the Safety and Tolerability of LY2603618 Administered 1 Day After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer. Invest New Drugs 31(1):136-44, 2013.
